CRE Recombinase Gesicles¸¦ ÀÌ¿ëÇÏ¿© Æ÷À¯·ù ¼¼Æ÷¿¡ ÀçÁ¶ÇÕ CRE ´Ü¹éÁúÀ» plasmid³ª virus¸¦ ÀÌ¿ëÇÏÁö ¾Ê°í ºü¸£°í È¿°úÀûÀ¸·Î Àü´Þ ÇÒ ¼ö ÀÖ´Ù. Gesicles´Â exosome-like vesiclesÇüÅ·Π³óÃàµÈ ÀçÁ¶ÇÕ CRE ´Ü¹éÁúÀ» ¸ñÀû ¼¼Æ÷·Î ¿î¹ÝÇÑ´Ù. ¼¼Æ÷³»·Î µµÀÔµÈ ÀçÁ¶ÇÕ CRE ´Ü¹éÁú¿¡´Â nuclear localization signalÀ» º¸À¯ÇÏ°í ÀÖ¾î ¼¼Æ÷ÇÙÀ¸·Î À̵¿ÇÏ¿© LoxP sitesÀÇ CRE-mediated recombination°¡ °¡´ÉÇϵµ·Ï ÇÑ´Ù.
Ư¡
What are the Benefits of Gesicle Technology?
Applications

±×¸² 1. Delivery of CRE recombinase into mammalian cells using gesicles. CRE Recombinase Gesicles are exosome-like vesicles that, when applied to your target cells, fuse with the plasma membrane and discharge CRE recombinase into the cell. CRE recombinase is transported to the nucleus via a nuclear localization signal where it can carry out CRE-mediated recombination between LoxP sites (top panel). Data was generated using a reporter cell line in which the LacZ gene is only expressed when the upstream, lox-flanked stop codon is excised by CRE recombinase (bottom panel, left and center images). CRE Recombinase Gesicles are labeled with the CherryPicker fluorescent protein, so treated target cells can be easily visualized by fluorescent microscopy (bottom panel, right hand image).


±×¸² 2. Rapid and efficient genome modification using CRE Recombinase Gesicles. A cell line harboring an integrated, loxP-conditional LacZ expression cassette (top panel) was either transfected for 6 hr with a plasmid expressing CRE recombinase (bottom panel, middle image) or treated with 20 ¥ìl CRE recombinase-containing gesicles for 3 hr (bottom panel, right image). 24 hr after treatment, cells were stained for LacZ expression using the Beta-Galactosidase Staining Kit from Clontech (Cat. No. 631780). The Beta Galactosidase gene is only expressed when the upstream loxP-flanked stop codon is excised by CRE recombinase. Results showed that, compared to plasmid transfection delivery of CRE recombinase, using gesicles resulted in faster and more efficient excision.